Cargando…
Curcumin Derivative C66 Suppresses Pancreatic Cancer Progression through the Inhibition of JNK-Mediated Inflammation
Pancreatic adenocarcinoma is by far the deadliest type of cancer. Inflammation is one of the important risk factors in tumor development. However, it is not yet clear whether deterioration in pancreatic cancer patients is related to inflammation, as well as the underlying mechanism. In addition, JNK...
Autores principales: | Chen, Hongjin, Jiang, Yuchen, Liu, Rongdiao, Deng, Jie, Chen, Qinbo, Chen, Lingfeng, Liang, Guang, Chen, Xiong, Xu, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147000/ https://www.ncbi.nlm.nih.gov/pubmed/35630552 http://dx.doi.org/10.3390/molecules27103076 |
Ejemplares similares
-
Inhibition Of JNK Phosphorylation By Curcumin Analog C66 Protects LPS-Induced Acute Lung Injury
por: Xiao, Zhongxiang, et al.
Publicado: (2019) -
Cardioprotective effects of the novel curcumin analogue C66 in diabetic mice is dependent on JNK2 inactivation
por: Li, Cheng, et al.
Publicado: (2018) -
Novel Curcumin C66 That Protects Diabetes-Induced Aortic Damage Was Associated with Suppressing JNK2 and Upregulating Nrf2 Expression and Function
por: Li, Cheng, et al.
Publicado: (2018) -
Inhibition of JNK Phosphorylation by Curcumin Analog C66 Protects LPS-Induced Acute Lung Injury [Corrigendum]
Publicado: (2022) -
Aprepitant Inhibits JNK and p38/MAPK to Attenuate Inflammation and Suppresses Inflammatory Pain
por: Yang, Yang, et al.
Publicado: (2022)